Psoriatic uveitis-associated cystoid macular oedema treated with intravitreal triamcinolone acetonide [3]

Acta Ophthalmologica Scandinavica

Volumn 84, Issue 3, 2006, Pages 436-

  Dhir, Luna ^a   Prasad, Som D ^a  

^a ARROWE PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPLEGIC AGENT; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; TOPICAL AGENT; TRIAMCINOLONE ACETONIDE;

ADULT; ARTHROPATHY; BLURRED VISION; CASE REPORT; CILIARY DISK; CRYOTHERAPY; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; FEMALE; HUMAN; HYPEREMIA; IMMUNOSUPPRESSIVE TREATMENT; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LETTER; OPHTHALMOSCOPY; OPTIC DISK; PRIORITY JOURNAL; PSORIASIS; RETINA MACULA CYSTOID EDEMA; UVEITIS; VISUAL ACUITY; VITRECTOMY;

ADULT; ARTHRITIS, PSORIATIC; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA, CYSTOID; TRIAMCINOLONE ACETONIDE; UVEITIS, INTERMEDIATE; VISUAL ACUITY; VITREOUS BODY;

EID: 33646768164     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2005.00614.x     Document Type: Letter

References (5)

1. Durrani K & Foster CS (2005): Psoriatic uveitis: a distinct clinical entity? Am J Ophthalmol 139: 106-111.
2. Jonas JB, Kreissig I, Sofker A & Degenring RF (2003): Intravitreal injection of triamcinolone for diffuse diabetic macular oedema. Arch Ophthalmol 121: 57-61.
3. Park CH, Jaffe GJ & Fekrat S (2003): Intravitreal triamcinolone acetonide in eyes with cystoid macular oedema associated with central retinal vein occlusion. Am J Ophthalmol 136: 419-425.
4. Rojas B, Zafirakis P, Christen W, Markomichelakis NN & Foster CS (1999): Medical treatment of macular oedema in patients with uveitis. Doc Ophthalmol 97: 399-407.
5. Young S, Larkin G, Branley M & Lightman S (2001): Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol 29: 2-6.